Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Prelude Therapeutics Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 57 | 61 | +4 |
| Shares | 34.5M | 36.0M | +1.51M (+4.4%) |
| Value | $986.6M | $1.12B | +$137.3M (+13.9%) |
New holders (9)
Institutions that held Prelude Therapeutics Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 15,559 | $486.0K | 0.00% |
| Citadel Advisors LLC | 14,495 | $453.0K | 0.00% |
| Parametric Portfolio Associates LLC | 10,130 | $317.0K | 0.00% |
| SG Americas Securities, LLC | 8,691 | $272.0K | 0.00% |
| Virtu Financial LLC | 7,940 | $248.0K | 0.02% |
| Credit Suisse AG | 6,950 | $216.0K | 0.00% |
| Point72 Hong Kong Ltd | 1,602 | $50.0K | 0.00% |
| Quantbot Technologies LP | 200 | $6.00K | 0.00% |
| US Bancorp | 158 | $5.00K | 0.00% |
Sold out (5)
Institutions that held Prelude Therapeutics Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Voloridge Investment Management, LLC | 15,319 | $439.0K |
| Jump Financial, LLC | 13,700 | $392.0K |
| Two Sigma Investments, LP | 10,116 | $290.0K |
| ARS Investment Partners, LLC | 7,400 | $212.0K |
| Dark Forest Capital Management LP | 155 | $4.00K |